Germany · Delayed Price · Currency is EUR Hoenle AG Earnings Call Transcripts
Fiscal Year 2026
-
Revenue remained stable year-over-year, with EBITDA up 26% to EUR 4.5 million, driven by Adhesive Systems and Disinfection growth. Curing segment remains challenged but shows signs of recovery, with full-year revenue expected at EUR 92–95 million and EBITDA at EUR 5–6 million.
-
Revenue and EBITDA improved sequentially, with Adhesive and Disinfection units showing growth, while Curing faced continued challenges from weak investment and customer insolvency. Full-year guidance is maintained, but expectations are toward the lower end due to market uncertainty.
-
Q1 sales and EBITDA were flat to slightly down year-over-year, with Disinfection showing strong growth while Curing lagged due to weak investment demand. Full-year guidance is maintained, with expectations for stronger performance in the second half and ongoing cost control.